Market Cap | 21.71M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -2.75M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 5.00% |
Sales | 13.34M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -8.00% |
Dividend | N/A | Price/Book | 48.35 | EPS next 5Y | - | 52W High Chg | -68.00% |
Recommedations | - | Quick Ratio | 0.26 | Shares Outstanding | 229.23M | 52W Low Chg | 57.00% |
Insider Own | 68.28% | ROA | -27.55% | Shares Float | 83.11M | Beta | 0.98 |
Inst Own | 5.63% | ROE | -4,292.19% | Shares Shorted/Prior | -/- | Price | 0.10 |
Gross Margin | 35.85% | Profit Margin | -20.59% | Avg. Volume | 78,962 | Target Price | - |
Oper. Margin | -36.03% | Earnings Date | Nov 12 | Volume | 115 | Change | 0.00% |
Charlie's Holdings, Inc., together with its subsidiaries, formulates, markets, and distributes non-combustible nicotine-related, alternative alkaloid vapor, and hemp-derived vapor and edible products. It sells its products through distributors, specialty retailers, and third-party online resellers in the United States, the United Kingdom, Italy, Spain, New Zealand, Australia, and Canada. Charlie's Holdings, Inc. was founded in 2014 and is headquartered in Costa Mesa, California.